A United Kingdom supplier, with 1 awarded contract, totalling £316k, most recently 3 months ago.
This contract is for the provision of Oncotype DX Breast Recurrence Score tests, which are essential for assessing the risk of breast cancer recurrence in patients. The contract is a call-off from an existing framework agreement, allowing the Norfolk and Norwich University Hospitals NHS Foundation T
